Almahmeed, Wael
Alabadla, Zainab
Al Awadi, Fatheya
Alrohmaihi, Dalal
AlShamiri, Mostafa
Elbadawi, Hussein
El-Tamimi, Hassan
Elzouki, Abdel-Nasser
Farghaly, Mohamed
Hafidh, Khadija
Hassanein, Mohamed
Hamad, Adel Khalifa
Khunti, Kamlesh
Sabbour, Hani
Schutte, Aletta E.
Funding for this research was provided by:
Servier
Article History
Received: 13 November 2024
Accepted: 20 December 2024
First Online: 22 January 2025
Declarations
:
: Wael Almahmeed, Zainab Alabadla, Fatheya Al Awadi, Dalal Alrohmaihi, Mostafa AlShamiri, Hussein Elbadawi, Hassan El-Tamimi, Abdel-Nasser Elzouki, Mohamed Farghaly, Khadija Hafidh, Mohamed Hassanein, Adel Khalifa Hamad, Kamlesh Khunti, Hani Sabbour, and Aletta E. Schutte have received honoraria for consultancy or advisory roles or speaker fees from Servier. In addition, Hussein Elbadawi has received honoraria for consultancy or advisory roles or speaker fees from Novo Nordisk, Sanofi, and Boehringer Ingelheim. Kamlesh Khunti has acted as a consultant/speaker or received grants for investigator-initiated studies from AstraZeneca, Bayer, Novo Nordisk, Sanofi Aventis, Servier, Lilly, MSD, Boehringer Ingelheim, Oramed Pharmaceuticals, Pfizer, Roche, Daiichi Sankyo, Applied Therapeutics, Embecta, and Nestlé Health Science. Hani Sabbour has received honoraria from Servier, which were all donated to patient-supporting charities in the United Arab Emirates. Aletta E. Schutte has received financial support from Servier, AstraZeneca, Medtronic, Abbott, Sanofi, Novartis, Aktiia, Omron, and Skylabs.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.